Smad linker region phosphorylation in the regulation of extracellular matrix synthesis

被引:59
作者
Burch, Micah L. [1 ,2 ,3 ]
Zheng, Wenhua [4 ]
Little, Peter J. [1 ,2 ,3 ]
机构
[1] BakerIDI Heart & Diabet Inst, Diabet & Cell Biol Lab, Melbourne, Vic 3004, Australia
[2] Monash Univ, Sch Med, Dept Med, Cent & Eastern Clin Sch, Prahran, Vic 3004, Australia
[3] Monash Univ, Sch Med, Dept Immunol, Cent & Eastern Clin Sch, Prahran, Vic 3004, Australia
[4] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangzhou 510080, Guangdong, Peoples R China
基金
英国医学研究理事会;
关键词
Transforming growth factor-beta; Smads; Phosphorylation; Signalling; Vascular smooth muscle; Collagen; Proteoglycans; GROWTH-FACTOR-BETA; VASCULAR SMOOTH-MUSCLE; MAD-RELATED PROTEIN; TGF-BETA; SIGNALING PATHWAYS; TRANSCRIPTIONAL ACTIVATION; PROTEOGLYCAN SYNTHESIS; CALCIUM MOBILIZATION; INCREASED BINDING; ANGIOTENSIN-II;
D O I
10.1007/s00018-010-0514-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The canonical TGF-beta signalling pathway involves Smad transcription factors through direct serine phosphorylation of the carboxy termini, nuclear translocation and regulation of transcription by receptor-regulated (R)-Smad complexes. Smads can also be phosphorylated in the linker region most prominently by the action of mitogen-activated protein (MAP) kinases, which in turn have been activated by TGF-beta or a multitude of other growth factors and hormones. Linker region phosphorylation can prevent nuclear translocation of Smads and inhibit TGF-beta signalling, potentially leading to oncogenesis. However, some evidence has revealed that linker region phosphorylated Smads can be translocated to the nucleus where they regulate transcription particularly of the synthesis of extracellular matrix molecules. Matrix molecules such as collagen and proteoglycans are involved in diseases such a fibrosis and atherosclerosis, respectively, and the involvement of linker region phosphorylation may represent a new therapeutic target.
引用
收藏
页码:97 / 107
页数:11
相关论文
共 72 条
[1]  
Agrotis Alex, 2005, Current Vascular Pharmacology, V3, P55, DOI 10.2174/1570161052773951
[2]   Nuclear CDKs Drive Smad Transcriptional Activation and Turnover in BMP and TGF-β Pathways [J].
Alarcon, Claudio ;
Zaromytidou, Alexia-Ileana ;
Xi, Qiaoran ;
Gao, Sheng ;
Yu, Jianzhong ;
Fujisawa, Sho ;
Barlas, Afsar ;
Miller, Alexandria N. ;
Manova-Todorova, Katia ;
Macias, Maria J. ;
Sapkota, Gopal ;
Pan, Duojia ;
Massague, Joan .
CELL, 2009, 139 (04) :757-769
[3]   Imatinib inhibits vascular smooth muscle proteoglycan synthesis and reduces LDL binding in vitro and aortic lipid deposition in vivo [J].
Ballinger, Mandy L. ;
Osman, Narin ;
Hashimura, Kazuhiko ;
de Haan, Judy B. ;
Jandeleit-Dahm, Karin ;
Allen, Terri ;
Tannock, Lisa R. ;
Rutledge, John C. ;
Little, Peter J. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (6B) :1408-1418
[4]   Endothelin-1 activates ETA receptors on human vascular smooth muscle cells to yield proteoglycans with increased binding to LDL [J].
Ballinger, Mandy L. ;
Ivey, Melanie E. ;
Osman, Narin ;
Thomas, Walter G. ;
Little, Peter J. .
ATHEROSCLEROSIS, 2009, 205 (02) :451-457
[5]   Regulation of glycosaminoglycan structure and atherogenesis [J].
Ballinger, ML ;
Nigro, J ;
Frontanilla, KV ;
Dart, AM ;
Little, PJ .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2004, 61 (11) :1296-1306
[6]  
BERK BC, 1987, J BIOL CHEM, V262, P5065
[7]   Oncogenic kinase signalling [J].
Blume-Jensen, P ;
Hunter, T .
NATURE, 2001, 411 (6835) :355-365
[8]   GROWTH-FACTOR ACTIVITY OF ENDOTHELIN ON VASCULAR SMOOTH-MUSCLE [J].
BOBIK, A ;
GROOMS, A ;
MILLAR, JA ;
MITCHELL, A ;
GRINPUKEL, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 258 (03) :C408-C415
[9]   TGF-β stimulates biglycan synthesis via p38 and ERK phosphorylation of the linker region of Smad2 [J].
Burch, Micah L. ;
Yang, Sundy N. Y. ;
Ballinger, Mandy L. ;
Getachew, Robel ;
Osman, Narin ;
Little, Peter J. .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2010, 67 (12) :2077-2090
[10]  
Cai Le, 2009, Expert Rev Gastroenterol Hepatol, V3, P1, DOI 10.1586/17474124.3.1.1